Platelet-endothelial interactions in atherosclerosis.

被引:39
|
作者
Sachais B.S. [1 ]
机构
[1] Department of Pathology and Laboratory Medicine, University of Pennsylvania, 207A John Morgan Building, 3620 Hamilton Walk, Philadelphia, 19104, PA
关键词
Human Umbilical Vein Endothelial Cell; Platelet Activate Factor; Nimesulide; Platelet Adhesion; Arterioscler Thromb Vasc Biol;
D O I
10.1007/s11883-001-0080-1
中图分类号
学科分类号
摘要
The pathogenesis of atherosclerosis, the leading cause of morbidity and mortality in the United States, is multifactorial. Many factors that have been shown to influence the development of atherosclerosis also affect the function of the endothelium through soluble or cell-cell interactions. Among these, interactions between platelets and endothelial cells have only recently begun to receive systematic study. This article reviews recent evidence showing how the interaction between platelets and endothelial cells may play a important role in the pathogenesis of atherosclerosis, suggesting an underappreciated potential locus for pharmacologic intervention.
引用
收藏
页码:412 / 416
页数:4
相关论文
共 50 条
  • [1] PARADOXICAL INFLUENCE OF ESTROGENIC HORMONES ON PLATELET-ENDOTHELIAL CELL-INTERACTIONS
    MILLER, ME
    DORES, GM
    THORPE, SL
    AKERLEY, WL
    THROMBOSIS RESEARCH, 1994, 74 (06) : 577 - 594
  • [2] Platelet-endothelial cell interactions modulate smooth muscle cell phenotype in an in vitro model of type 2 diabetes mellitus
    Zeng, Min
    Luo, Yulin
    Xu, Chunrong
    Li, Rong
    Chen, Ni
    Deng, Xin
    Fang, Dan
    Wang, Liqun
    Wu, Jianbo
    Luo, Mao
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2019, 316 (02): : C186 - C197
  • [3] The role of chemokines in atherosclerosis.
    Mach F.
    Current Atherosclerosis Reports, 2001, 3 (3) : 243 - 251
  • [4] Genetic determinants of diabetes and atherosclerosis.
    Mitchell B.D.
    Imumorin I.G.
    Current Atherosclerosis Reports, 2002, 4 (3) : 193 - 198
  • [5] Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis.
    Sherer Y.
    Shoenfeld Y.
    Current Atherosclerosis Reports, 2001, 3 (4) : 328 - 333
  • [6] Hormone replacement therapy in the prevention and treatment of atherosclerosis.
    Mosca L.
    Current Atherosclerosis Reports, 2000, 2 (4) : 297 - 302
  • [7] Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis.
    Geng Y.J.
    Current Atherosclerosis Reports, 2001, 3 (3) : 234 - 242
  • [8] The role of non-LDL:non-HDL particles in atherosclerosis.
    Segrest J.P.
    Current Diabetes Reports, 2002, 2 (3) : 282 - 288
  • [9] High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis.
    Kawashiri M.A.
    Maugeais C.
    Rader D.J.
    Current Atherosclerosis Reports, 2000, 2 (5) : 363 - 372
  • [10] Endothelial arginase: A new target in atherosclerosis
    Zhihong Yang
    Xiu-Fen Ming
    Current Hypertension Reports, 2006, 8 : 54 - 59